Clinical Trial Update: Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Wagner Grade 2 Foot Ulcers. [Phase 3]

View source ↗

Summary

Phase 3 trial update reporting the completion of a study evaluating the efficacy and safety of ALLO-ASC-DFU for diabetic foot ulcers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer

Drugs mentioned

• ALLO-ASC-DFU

Snippet

Sponsor: Anterogen Co., Ltd. | Conditions: Diabetic Foot Ulcer | Phase 3 | Status: COMPLETED